115 related articles for article (PubMed ID: 10587105)
1. Radiolabelled 5'-iodo-2'-deoxyuridine: a promising alternative to [18F]-2-fluoro-2-deoxy-D-glucose for PET studies of early response to anticancer treatment.
Carnochan P; Brooks R
Nucl Med Biol; 1999 Aug; 26(6):667-72. PubMed ID: 10587105
[TBL] [Abstract][Full Text] [Related]
2. Uptake of radiolabelled tyrosine and iodo-methyl tyrosine in experimental rat tumours: influence of blood flow and tumour growth rate.
Carnochan P; Deehan B; Trivedi M; Tombs A; Sandle J; Ott R
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):92-5. PubMed ID: 7632776
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Brain Nuclear Medicine Imaging Tracers in a Murine Model of Sepsis-Associated Encephalopathy.
Szöllősi D; Hegedűs N; Veres DS; Futó I; Horváth I; Kovács N; Martinecz B; Dénes Á; Seifert D; Bergmann R; Lebeda O; Varga Z; Kaleta Z; Szigeti K; Máthé D
Mol Imaging Biol; 2018 Dec; 20(6):952-962. PubMed ID: 29736562
[TBL] [Abstract][Full Text] [Related]
4. Uptake and distribution of L-3-[I-125] iodo-alpha-methyl tyrosine in experimental rat tumours: comparison with blood flow and growth rate.
Deehan B; Carnochan P; Trivedi M; Tombs A
Eur J Nucl Med; 1993 Feb; 20(2):101-6. PubMed ID: 8440265
[TBL] [Abstract][Full Text] [Related]
5. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography.
Moore JV; Waller ML; Zhao S; Dodd NJ; Acton PD; Jeavons AP; Hastings DL
Eur J Nucl Med; 1998 Sep; 25(9):1248-54. PubMed ID: 9724373
[TBL] [Abstract][Full Text] [Related]
7. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine.
Tjuvajev JG; Macapinlac HA; Daghighian F; Scott AM; Ginos JZ; Finn RD; Kothari P; Desai R; Zhang J; Beattie B
J Nucl Med; 1994 Sep; 35(9):1407-17. PubMed ID: 8071684
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.
Bentzen L; Keiding S; Horsman MR; Falborg L; Hansen SB; Overgaard J
Acta Oncol; 2000; 39(5):629-37. PubMed ID: 11093372
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and biodistribution of radiolabelled idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapy.
Young H; Carnochan P; Trivedi M; Potter GA; Eccles SA; Haynes BP; Jarman M; Ott RJ
Nucl Med Biol; 1995 May; 22(4):405-11. PubMed ID: 7550016
[TBL] [Abstract][Full Text] [Related]
10. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine.
Blasberg RG; Roelcke U; Weinreich R; Beattie B; von Ammon K; Yonekawa Y; Landolt H; Guenther I; Crompton NE; Vontobel P; Missimer J; Maguire RP; Koziorowski J; Knust EJ; Finn RD; Leenders KL
Cancer Res; 2000 Feb; 60(3):624-35. PubMed ID: 10676646
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and kinetics of radiolabelled pyrrolidino-4-iodo-tamoxifen: prospects for pharmacokinetic studies using PET.
Carnochan P; Trivedi M; Young H; Eccles S; Potter G; Haynes B; Ott R
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):96-8. PubMed ID: 7632777
[TBL] [Abstract][Full Text] [Related]
12. Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma.
Kaarstad K; Bender D; Bentzen L; Munk OL; Keiding S
J Nucl Med; 2002 Jul; 43(7):940-7. PubMed ID: 12097467
[TBL] [Abstract][Full Text] [Related]
13. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
[TBL] [Abstract][Full Text] [Related]
14. The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.
Philip PA; Kaklamanis L; Carmichael J; Tonkin K; Morrison H; Gatter K; Harris AL
Br J Cancer; 1993 Apr; 67(4):644-9. PubMed ID: 8471420
[TBL] [Abstract][Full Text] [Related]
15. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
Semnani ES; Wang K; Adelstein SJ; Kassis AI
J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
[TBL] [Abstract][Full Text] [Related]
17. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.
Adams S; Baum R; Rink T; Schumm-Dräger PM; Usadel KH; Hör G
Eur J Nucl Med; 1998 Jan; 25(1):79-83. PubMed ID: 9396878
[TBL] [Abstract][Full Text] [Related]
18. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
